Safety and Efficacy of Tocilizumab Versus Azathioprine in Neuromyelitis Optica Spectrum Disorders: a Randomized, Controlled, Open-label, Phase 2 Trial
Latest Information Update: 07 Apr 2022
Price :
$35 *
At a glance
- Drugs Tocilizumab (Primary) ; Azathioprine
- Indications Neuromyelitis optica
- Focus Therapeutic Use
- Acronyms TANGO
- 26 Feb 2022 Results presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2022
- 22 Oct 2019 Status changed from active, no longer recruiting to completed.
- 13 Aug 2018 Status changed from recruiting to active, no longer recruiting.